These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 659985)

  • 21. Oral ursodeoxycholic acid tolerance test in patients with digestive disease.
    Yamanishi Y; Kishimoto Y; Kawasaki H; Hirayama C; Ikawa S
    Gastroenterol Jpn; 1981; 16(5):472-7. PubMed ID: 7327385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, intestinal absorption and metabolism of sarcosine conjugated ursodeoxycholic acid.
    Kimura M; Hatono S; Une M; Fukuoka C; Kuramoto T; Hoshita T
    Steroids; 1984 Jun; 43(6):677-87. PubMed ID: 6533845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique.
    Riad-Fahmy D; Read GF; Gaskell SJ; Dyas J; Hindawi R
    Clin Chem; 1979 May; 25(5):665-8. PubMed ID: 436230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects.
    van Erpecum KJ; van Berge Henegouwen GP; Stolk MF; Hopman WP; Jansen JB; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):836-42. PubMed ID: 2199291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay.
    Clemens TL; Hendy GN; Papapoulos SE; Fraher LJ; Care AD; O'Riordan JL
    Clin Endocrinol (Oxf); 1979; 11(2):225-34. PubMed ID: 487620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay of bencyclane in human serum.
    Mohri Z; Yasuda T; Kawahara K; Shono F; Yoshitake A
    J Pharmacobiodyn; 1985 Mar; 8(3):227-33. PubMed ID: 4009414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone.
    Kanazawa Y; Koizumi M; Hirakawa H; Endo K; Yoshida S; Miyakawa T; Konno Y; Goto Y; Goto J; Nambara T
    Tohoku J Exp Med; 1982 Mar; 136(3):235-49. PubMed ID: 7071843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct radioimmunoassay for haloperidol in human serum.
    Terauchi Y; Ishikawa S; Oida S; Nakao M; Kagemoto A; Oida T; Utsui Y; Sekine Y
    J Pharm Sci; 1990 May; 79(5):432-6. PubMed ID: 2352164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate.
    Fromm H; Sarva RP; Bazzoli F
    J Lipid Res; 1983 Jul; 24(7):841-53. PubMed ID: 6631218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A radioimmunoassay of bile acids.
    Hashimoto S; Chikai T; Uchida K
    J Immunoassay; 1990; 11(3):355-72. PubMed ID: 2229424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid for chronic liver diseases.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preparation and properties of an antiserum for the radioimmunoassay of serum conjugated cholic acid.
    Murphy GM; Edkins SM; Williams JW; Catty D
    Clin Chim Acta; 1974 Jul; 54(1):81-9. PubMed ID: 4858772
    [No Abstract]   [Full Text] [Related]  

  • 35. A simplified radioimmunoassay of plasma nortriptyline in depressed patients compared with high-pressure liquid chromatography and gas-liquid chromatography.
    Sayegh JF
    Neurochem Res; 1986 Feb; 11(2):193-206. PubMed ID: 3703101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 3 beta, 7 beta-dihydroxy-5 beta-cholan-24-oic acid in serum from patients treated with ursodeoxycholic acid.
    Maeda M; Ohama H; Takeda H; Yabe M; Nambu M; Namihisa T
    J Lipid Res; 1984 Jan; 25(1):14-26. PubMed ID: 6707518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N
    Gastroenterology; 1990 Aug; 99(2):533-5. PubMed ID: 2365199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
    Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
    Leuschner U; Fischer H; Kurtz W; Güldütuna S; Hübner K; Hellstern A; Gatzen M; Leuschner M
    Gastroenterology; 1989 Nov; 97(5):1268-74. PubMed ID: 2551765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.